Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2011 2
2012 1
2013 1
2014 1
2016 1
2018 2
2020 3
2021 2
2022 2
2023 3
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group.
Mendoza N, Ramírez I, de la Viuda E, Coronado P, Baquedano L, Llaneza P, Nieto V, Otero B, Sánchez-Méndez S, de Frutos VÁ, Andraca L, Barriga P, Benítez Z, Bombas T, Cancelo MJ, Cano A, Branco CC, Correa M, Doval JL, Fasero M, Fiol G, Garello NC, Genazzani AR, Gómez AI, Gómez MÁ, González S, Goulis DG, Guinot M, Hernández LR, Herrero S, Iglesias E, Jurado AR, Lete I, Lubián D, Martínez M, Nieto A, Nieto L, Palacios S, Pedreira M, Pérez-Campos E, Plá MJ, Presa J, Quereda F, Ribes M, Romero P, Roca B, Sánchez-Capilla A, Sánchez-Borrego R, Santaballa A, Santamaría A, Simoncini T, Tinahones F, Calaf J. Mendoza N, et al. Among authors: de la viuda e. Maturitas. 2022 Dec;166:65-85. doi: 10.1016/j.maturitas.2022.08.008. Epub 2022 Aug 30. Maturitas. 2022. PMID: 36081216
Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review.
Fiol G, Lete I, Nieto L, Santaballa A, Pla MJ, Baquedano L, Calaf J, Coronado P, de la Viuda E, Llaneza P, Otero B, Sánchez-Méndez S, Ramírez I, Mendoza N; “HMT Elegibility Criteria Group”. Fiol G, et al. Among authors: de la viuda e. J Clin Med. 2023 Aug 12;12(16):5263. doi: 10.3390/jcm12165263. J Clin Med. 2023. PMID: 37629305 Free PMC article. Review.
Population-based survey on menopausal symptoms and treatment use.
Baquedano L, Coronado P, De la Viuda E, Sánchez S, Otero B, Ramírez I, Llaneza P, Mendoza N. Baquedano L, et al. Among authors: de la viuda e. Climacteric. 2023 Feb;26(1):47-54. doi: 10.1080/13697137.2022.2139598. Epub 2022 Nov 9. Climacteric. 2023. PMID: 36351874
Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis.
Coronado PJ, Gómez A, Iglesias E, Fasero M, Baquedano L, Sánchez S, Ramírez-Polo I, de la Viuda E, Otero B, Llaneza P, Mendoza N, Lubián DM; HMT Eligibility Criteria Group. Coronado PJ, et al. Among authors: de la viuda e. Menopause. 2024 Mar 1;31(3):234-242. doi: 10.1097/GME.0000000000002317. Menopause. 2024. PMID: 38385734
Response to "Should estrogen be used in the co-treatment of COVID-19 patients?".
Cano A, Ramírez I, De la Viuda E, Baquedano L, Coronado P, Llaneza P, Otero B, Sánchez S, Cancelo MJ, Páramo JA, Mendoza N. Cano A, et al. Among authors: de la viuda e. Maturitas. 2020 Oct;140:81-82. doi: 10.1016/j.maturitas.2020.06.014. Epub 2020 Jul 31. Maturitas. 2020. PMID: 32747134 Free PMC article. No abstract available.
The thromboembolic risk in covid-19 women under hormonal treatment group.
Ramírez I, De la Viuda E, Baquedano L, Coronado P, Llaneza P, Mendoza N, Otero B, Sánchez S, Cancelo MJ, Páramo JA, Cano A. Ramírez I, et al. Among authors: de la viuda e. Maturitas. 2020 Aug;138:78-79. doi: 10.1016/j.maturitas.2020.05.021. Epub 2020 Jun 18. Maturitas. 2020. PMID: 32565010 Free PMC article. No abstract available.
Position of the Spanish Menopause Society regarding the management of perimenopause.
Mendoza N, Sánchez-Borrego R, Cancelo MJ, Calvo A, Checa MA, Cortés J, Elorriaga MA, Díaz T, González JV, Lete I, Lobo P, Martínez-Astorquiza T, Nieto A, Olalla MA, Pérez-Campos E, Porqueras R, Quereda F, Salamanca A, De La Viuda E; Spanish Menopause Society, EMAS. Mendoza N, et al. Among authors: de la viuda e. Maturitas. 2013 Mar;74(3):283-90. doi: 10.1016/j.maturitas.2012.12.010. Epub 2013 Jan 14. Maturitas. 2013. PMID: 23332610
19 results